References
- Old J. M., Khan S. N., Verma I., Fucharoen S., Kleanthous M., Ioannou P., Kotea N., Fisher C., Riazuddin S., Saxena R., Winichagoon P., Kyriacou K., Al‐Quobaili F., Khan B. A multi‐center study in order to further define the molecular basis of β‐thalassemia in Thailand, Pakistan, Sri Lanka, Mauritius, Syria, and India and to develop a simple molecular diagnostic strategy by amplification refractory mutation system‐polymerase chain reaction. Hemoglobin 2001; 25(4)397–407
- Krugluger W., Hopmeier P. Identification of a compound β‐thalassemia homozygosity [codon 10 (GCC→GCA) and codon 16 (−C)] in an Afghan family. Hemoglobin 2002; 26(3)317–320
- Pawar A. R., Colah R. B., Mohanty D. A novel β+ thalassemia mutation (codon 10 GCC→GCA) and a rare transcriptional mutation (−28 A→G) in Indians. Blood 1997; 89: 3888–3889
- Huisman T. H.J., Carver M. F.H., Efremov G. D. A Syllabus of Human Hemoglobin Variants2nd. The Sickle Cell Anemia Foundation, Augusta 1998, (http://globin.cse.psu.edu)